Revenue
-
Net Income
-$23.5M
▲ 30.9% YoY
EPS
$-0.32
▲ 62.8% YoY
Cash
$36.8M
▲ 47.2% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Doyle John Brendan Chief Financial Officer | Buy | Apr 16, 2026 | 10.0K | $1.13 | $11K | Form 4 ↗ |
Ricciardi Lisa CEO & President | Buy | Apr 16, 2026 | 9.2K | $1.10 | $10K | Form 4 ↗ |
Caggiano Anthony Chief Medical Officer | Buy | Apr 16, 2026 | 10.0K | $1.11 | $11K | Form 4 ↗ |
Ricciardi Lisa CEO & President | Sell tax | Feb 15, 2026 | 5.8K | $1.12 | $7K | Form 4 ↗ |
Doyle John Brendan Chief Financial Officer | Sell tax | Feb 15, 2026 | 1.6K | $1.12 | $2K | Form 4 ↗ |
Caggiano Anthony Chief Medical Officer | Sell tax | Feb 15, 2026 | 4.7K | $1.12 | $5K | Form 4 ↗ |
Ricciardi Lisa CEO & President | Sell tax | Feb 4, 2026 | 51.7K | $1.03 | $53K | Form 4 ↗ |
Doyle John Brendan Chief Financial Officer | Sell tax | Feb 4, 2026 | 26.9K | $1.03 | $28K | Form 4 ↗ |
Caggiano Anthony Chief Medical Officer | Sell tax | Feb 4, 2026 | 26.9K | $1.03 | $28K | Form 4 ↗ |
Ricciardi Lisa CEO & President | Grant | Feb 3, 2026 | 800.0K | $0.00 | $0 | Form 4 ↗ |
Ricciardi Lisa CEO & President | Sell tax | Feb 3, 2026 | 26.0K | $1.12 | $29K | Form 4 ↗ |
Doyle John Brendan Chief Financial Officer | Grant | Feb 3, 2026 | 200.0K | $0.00 | $0 | Form 4 ↗ |
Caggiano Anthony Chief Medical Officer | Grant | Feb 3, 2026 | 400.0K | $0.00 | $0 | Form 4 ↗ |
Caggiano Anthony Chief Medical Officer | Sell tax | Feb 3, 2026 | 11.5K | $1.12 | $13K | Form 4 ↗ |